Loading insider details...
Beta
Latest Form 4 (Jul 8, 2026): Exercise/Conversion of 680 DMRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | Damora Therapeutics, Inc. (DMRA) | Exercise/Conversion | 680 | n/a |
| Mar 25, 2026 | Damora Therapeutics, Inc. (DMRA) | Grant/Award | 250,000 | n/a |
| Jan 6, 2026 | Galecto, Inc. (GLTO) | Exercise/Conversion | 680 | n/a |
| Jul 8, 2025 | Galecto, Inc. (GLTO) | Exercise/Conversion | 680 | n/a |
| Jan 7, 2025 | Galecto, Inc. (GLTO) | Exercise/Conversion | 1,320 | n/a |
| Oct 11, 2024 | Galecto, Inc. (GLTO) | Grant/Award | 15,600 | n/a |
| Jan 5, 2024 | Galecto, Inc. (GLTO) | Grant/Award | 100,000 | n/a |
| Jan 5, 2023 | Galecto, Inc. (GLTO) | Grant/Award | 80,000 | n/a |
| Jan 6, 2022 | Galecto, Inc. (GLTO) | Grant/Award | 75,000 | n/a |
| Dec 6, 2021 | Galecto, Inc. (GLTO) | Purchase | 2,000 | $5.0K |